Gene · 2288
Papers1,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis. | Front Oncol | 2023 | 38130989 | PubTator, text mining | PubMed |
| Stress, a Brief Update. | Int J Psychol Res (Medellin) | 2023 | 38106958 | PubTator, text mining | PubMed |
| Stress-related cellular pathophysiology as a crosstalk risk factor for neurocognitive and psychiatric disorders. | BMC Neurosci | 2023 | 38087196 | PubTator, text mining | PubMed |
| Unveiling Distinct Proteomic Signatures in Complicated Crohn's Disease That Could Predict the Disease Course. | Int J Mol Sci | 2023 | 38069288 | PubTator, text mining | PubMed |
Evaluating the Efficacy and Safety of a Single-Dose Tranexamic Acid in Reducing Blood Loss During Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy: A Randomized Comparative Pilot Study. | Anesth Pain Med | 2023 | 38024001 | PubTator, text mining | PubMed |
| The Pathological Role of miRNAs in Endometriosis. | Biomedicines | 2023 | 38002087 | PubTator, text mining | PubMed |
| Broad-spectrum metastasis suppressing compounds and therapeutic uses thereof in human tumors. | Sci Rep | 2023 | 37990044 | PubTator, text mining | PubMed |
| FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer. | J Int Med Res | 2023 | 37987640 | PubTator, text mining | PubMed |
| An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions. | EMBO J | 2023 | 37987160 | PubTator, text mining | PubMed |
| Research progress of glucocorticoid resistance in chronic rhinosinusitis with nasal polyps: A review. | Medicine (Baltimore) | 2023 | 37986338 | PubTator, text mining | PubMed |
| Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses. | Explor Target Antitumor Ther | 2023 | 37970210 | PubTator, text mining | PubMed |
| Unveiling the Molecular Landscape of FOXA1 Mutant Prostate Cancer: Insights and Prospects for Targeted Therapeutic Strategies. | Int J Mol Sci | 2023 | 37958805 | PubTator, text mining | PubMed |
| Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor. | Nat Struct Mol Biol | 2023 | 37945740 | PubTator, text mining | PubMed |
| Large-scale, in-cell photocrosslinking at single-residue resolution reveals the molecular basis for glucocorticoid receptor regulation by immunophilins. | Nat Struct Mol Biol | 2023 | 37945739 | PubTator, text mining | PubMed |
| A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn's Disease Treated by a Multidisciplinary Team: 1-Year Outcomes. | Crohns Colitis 360 | 2023 | 37941598 | PubTator, text mining | PubMed |
| LncRNA MAFG-AS1 is involved in human cancer progression. | Eur J Med Res | 2023 | 37941063 | PubTator, text mining | PubMed |
| In-depth single-cell and bulk-RNA sequencing developed a NETosis-related gene signature affects non-small-cell lung cancer prognosis and tumor microenvironment: results from over 3,000 patients. | Front Oncol | 2023 | 37927467 | PubTator, text mining | PubMed |
| Hyperthermia Enhances Adeno-Associated Virus Vector Transduction Efficiency in Melanoma Cells. | Curr Issues Mol Biol | 2023 | 37886980 | PubTator, text mining | PubMed |
| Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method. | J Chem Inf Model | 2023 | 37847557 | PubTator, text mining | PubMed |
| Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension. | Int J Mol Sci | 2023 | 37834471 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2288/papers?page=6